Ep 39. UK JIA Biologics Register: stopping biologics for remission

Talking Rheumatology Research

What happens when children and young people with JIA stop biologic therapies for remission? Dr Lianne Kearsley-Fleet and Dr Coziana Ciurtin join Dr Herman Tam to discuss their analysis of the UK JIA Biologics Register.
Lianne is an epidemiologist and lead analyst of the UK JIA Biologics Register, based at the University of Manchester. Coziana is a consultant rheumatologist based at University College London.
Managed by the University of Manchester, the UK JIA Biologics Register is a collaboration between BSR and Versus Arthritis that measures the safety and effectiveness of biologic and biosimilar treatment for juvenile idiopathic arthritis.
Want to find out more? Here's your further reading list:
1. Read Lianne and Coziana's full paper
2. Find out more about the UK JIA Biologics Register
3. Explore research from the BSR biologics registers

Registration is open for BSR's Annual Conference. As the UK's leading rheumatology event, we bring together over 2,000 delegates for three days of learning, knowledge sharing, networking and innovation. Book your ticket today!

Thanks for listening to Talking Rheumatology Research! Join the conversation on Twitter using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram.
Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.